<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654461/bin/1471-2407-9-72-2.jpg"/> </div> <div class="text-side"> <h1>Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications.</h1> <p>Immunohistochemistry for topoIIα in salivary gland tumors. A: Pleomorphic adenoma: few positive nuclear expressions in tumor cells (×100). B: Warthin's tumor: abundant positive expression in lymphoid cells of germinal centers, not in epithelial tumor cells (×100). C: Adenoid cystic carcinoma (Grade 1): low expression in low-grade tubular components (×100). D: Adenoid cystic carcinoma (Grade 3): high nuclear expression in high-grade solid areas (×100). E: Salivary duct carcinoma: many positive cells in foci with typical comedonecrosis (×100). F: Salivary duct carcinoma: strong and diffuse expression observed in the invasive micropapillary variant (×200).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/19250538/" target="_blank">19250538</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>